PMID
Cmpds
Data
Article Title
Organization
48
Design of Potent Small-Molecule Stimulator of Interferon Gene Inhibitor and Stimulator of Interferon Gene Mutant-Specific Degrader.

University of Michigan
25
Synthesis and structure-activity evaluation of a series of novel tricyclic STING activators.

Curadev Pharma Pvt. Ltd.
3
Design, synthesis, and activity evaluation of novel STING inhibitors based on C170 and H151.

Ocean University of China
53
Design of an Oral STING Agonist through Intramolecular Hydrogen Bond Ring Mimicking to Achieve Complete Tumor Regression.

University of Michigan
24
Discovery of 3-(Fluoro-imidazolyl)pyridazine Derivatives as Potent STING Agonists with Antitumor Activity.

Chinese Academy of Sciences
27
Design, Synthesis, and Biological Evaluation of Selective STING Synergists That Enhance cGAMP-STING Pathway Activation without Inherent Agonist Activity.

Beijing Institute of Pharmacology & Toxicology
36
Discovery of an Orally Bioavailable STING Inhibitor with In Vivo Anti-Inflammatory Activity in Mice with STING-Mediated Inflammation.

China Pharmaceutical University
44
Discovery of Potent STING Inhibitors Bearing a Difluorobenzodioxol Structural Motif as Potent Anti-Inflammatory Agents.

Shanghai Jiao Tong University
4
Orally Bioavailable and Site-Selective Covalent STING Inhibitor Derived from a Macrocyclic Marine Diterpenoid.

National Health Research Institutes
8
Discovery of novel amidobenzimidazole derivatives as orally available small molecule modulators of stimulator of interferon genes for cancer immunotherapy.

Korea Research Institute of Chemical Technology
18
Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy.

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
2
Design and Assessment of First-Generation Heterobifunctional PPARα/STING Modulators.

University of Minnesota
20
Non-kinase off-target inhibitory activities of clinically-relevant kinase inhibitors.

Purdue University
3
Perspectives on Nuclear Magnetic Resonance Spectroscopy in Drug Discovery Research.

Bristol Myers Squibb
5
PDE-stable 2'3'-cGAMP analogues, containing 5'-S-phosphorothioester linkage, as STING agonists.

Purdue University
15
Macrocyclization strategy for improving candidate profiles in medicinal chemistry.

Gachon University
13
Analysis of structure-activity relationship of indol-3-yl-N-phenylcarbamic amides as potent STING inhibitors.

National Health Research Institutes
71
Development of Orally Bioavailable Amidobenzimidazole Analogues Targeting Stimulator of Interferon Gene (STING) Receptor.

China Pharmaceutical University
22
Structure-Activity Relationship Study of 1

University of Chinese Academy of Sciences
25
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates.

Mersana Therapeutics
6
S-acylthioalkyl ester (SATE)-based prodrugs of deoxyribose cyclic dinucleotides (dCDNs) as the STING agonist for antitumor immunotherapy.

Nankai University
14
Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of Cancer.

Boehringer Ingelheim Pharma
89
Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists.

Peking Union Medical College
9
A comprehensive review on acridone based derivatives as future anti-cancer agents and their structure activity relationships.

Svkm'S Nmims
3
STING antagonists, synthesized

Purdue University
28
Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists.

Fudan University
3
Identification of (-)-Epigallocateshin gallate derivatives promoting innate immune activation via 2',3'-cyclic GMP-AMP-stimulator of interferon genes pathway.

Korea Institute of Science and Technology
50
If small molecules immunotherapy comes, can the prime be far behind?

Zhejiang University
2
Discovery of Selenium-Containing STING Agonists as Orally Available Antitumor Agents.

China Pharmaceutical University
1
Novel CRBN-Recruiting Proteolysis-Targeting Chimeras as Degraders of Stimulator of Interferon Genes with In Vivo Anti-Inflammatory Efficacy.

Southern Medical University
21
Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer.

Merck
21
Development of Potent Immune Modulators Targeting Stimulator of Interferon Genes Receptor.

Korea Research Institute of Chemical Technology
22
Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration.

China Pharmaceutical University
6
Structure-Activity relationship study of benzothiophene oxobutanoic acid analogues leading to novel stimulator of interferon gene (STING) agonists.

Shanghai Jiao Tong University
25
Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors.

Roche Innovation Center Shanghai
18
STING, a promising target for small molecular immune modulator: A review.

China Pharmaceutical University
23
Discovery of Non-Nucleotide Small-Molecule STING Agonists

Bristol Myers Squibb
21
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route.

Takeda Pharmaceuticals International
25
Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3',3'-c-Di(2'F,2'dAMP).

Institute of Organic Chemistry and Biochemistry of The Czech Academy of Sciences
17
Structure-Activity Relationship Study of Amidobenzimidazole Analogues Leading to Potent and Systemically Administrable Stimulator of Interferon Gene (STING) Agonists.

Chinese Academy of Sciences
2
The discovery of potent small molecule activators of human STING.

Curadev Pharma
13
Design, Synthesis, and Biological Evaluation of Novel Cyclic Adenosine-Inosine Monophosphate (cAIMP) Analogs That Activate Stimulator of Interferon Genes (STING).

Invivogen
10
Targeting Stimulator of Interferon Genes (STING) for the Potential Treatment of Cancer and Infectious Diseases.

Usona Institute
7
Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants.

Nankai University
6
Novel Compounds as STING Modulators for Treating Hepatitis B Virus Infections.

Smith, Gambrell & Russell
6
Potential Cancer Treatment by Agonists of the Stimulator of Interferon Genes.

Therachem Research Medilab
13
Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING.

Merck
28
Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective.

China Pharmaceutical University
39
Enzymatic Preparation of 2'-5',3'-5'-Cyclic Dinucleotides, Their Binding Properties to Stimulator of Interferon Genes Adaptor Protein, and Structure/Activity Correlations.

Institute of Organic Chemistry and Biochemistry of The Czech Academy of Sciences and Gilead Sciences Research Centre At Iocb
2
STING modulators: Predictive significance in drug discovery.

Zhejiang Normal University
47
Design, Synthesis, and Biological Evaluation of Amidobenzimidazole Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists.

Peking Union Medical College
17
Macrolide derivatives, preparation method and application thereof

Zhejiang Hisun Pharmaceutical
6
KRAS INHIBITOR COMPOUND

Shanghai Apeiron Therapeutics Company
100
PYRIMIDINES AND METHODS OF THEIR USE

Kineta
22
COMPOSITION AND METHOD FOR TREATMENT OF GRAM NEGATIVE BACTERIAL INFECTION

The State University of New York
15
Decarboxylase inhibitors for treating Parkinson's disease

Sail Biomedicines
5
Pyridopyrimidine derivative, preparation method therefor and medical use thereof

Jiangsu Hengrui Medicine Co.
22
PREPARATION AND APPLICATION METHOD OF HETEROCYCLIC COMPOUNDS AS KRAS INHIBITOR

Shanghai Kechow Pharma
44
NAPHTHYRIDINE AND PYRIDO[3,4-c]PYRIDAZINE DERIVATIVES AS GABAA ALPHA 5 RECEPTOR MODULATORS

Richter Gedeon
163
QUINAZOLINONES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME

Repare Therapeutics
252
Pyrazole MAGL inhibitors

H. Lundbeck
13
Bipyrazole derivatives as JAK inhibitors

Incyte
25
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease

Shy Therapeutics
137
Compounds and methods useful in the treatment of a PRMT5-mediated disorder

Argonaut Therapeutics
71
Imidazopyridazine and imidazopyridine compounds and uses thereof

Incyte
4
Amide derivatives as Nav1.7 and Nav1.8 blockers

Raqualia Pharma
3
PRMT5 inhibitors

Ctxt
294
Pyrimidine derivative

ASKA Pharmaceutical Co